Literature DB >> 11834652

Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction.

Jeffrey W H Fung1, Thomas S T Li, Dominic K L Choy, Gabriel W K Yip, Fanny W S Ko, John E Sanderson, David S C Hui.   

Abstract

INTRODUCTION: Hypertension is common in patients with obstructive sleep apnea (OSA). However, the effect of OSA on ventricular function, especially diastolic function, is not clear. Therefore, we have assessed the prevalence of diastolic dysfunction in patients with OSA and the relationship between diastolic parameters and severity of OSA.
METHODS: Sixty-eight consecutive patients with OSA confirmed by polysomnography underwent echocardiography. Diastolic function of the left ventricle was determined by transmitral valve pulse-wave Doppler echocardiography. Various baseline characteristics, severity of OSA, and echocardiographic parameters were compared between patients with and without diastolic dysfunction.
RESULTS: There were 61 male and 7 female patients with a mean age of 48.1 +/- 11.1 years, body mass index of 28.5 +/- 4.3 kg/m(2), and apnea/hypopnea index (AHI) of 44.3 +/- 23.2/h (mean +/- SD). An abnormal relaxation pattern (ARP) in diastole was noted in 25 patients (36.8%). Older age (52.7 +/- 8.9 years vs 45.1 +/- 11.3 years, p = 0.005), hypertension (56% vs 20%, p = 0.002), and a lower minimum pulse oximetric saturation (SpO(2)) during sleep (70.5 +/- 17.9% vs 78.8 +/- 12.9%, respectively; p = 0.049) were more common in patients with ARP. By multivariate analysis, minimum SpO(2) < 70% was an independent predictor of ARP (odds ratio, 4.34; 95% confidence interval, 1.23 to 15.25; p = 0.02) irrespective of age and hypertension. Patients with AHI > or = 40/h had significantly longer isovolumic relaxation times than those with AHI < 40/h (106 +/- 19 ms vs 93 +/- 17 ms, respectively; p = 0.005).
CONCLUSION: Diastolic dysfunction with ARP was common in patients with OSA. More severe sleep apnea was associated with a higher degree of left ventricular diastolic dysfunction in this study.

Entities:  

Mesh:

Year:  2002        PMID: 11834652     DOI: 10.1378/chest.121.2.422

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  60 in total

1.  Obstructive sleep apnea and heart failure.

Authors:  Andrew D Calvin; Felipe N Albuquerque; Taro Adachi; Virend K Somers
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-12

2.  Left ventricular subclinical dysfunction associated with myocardial deformation changes in obstructive sleep apnea patients estimated by real-time 3D speckle-tracking echocardiography.

Authors:  Dian Wang; Gen Shan Ma; Xiao Yan Wang; Qiang Qiang Lu; Yu Wang; Nai Feng Liu
Journal:  Sleep Breath       Date:  2015-05-24       Impact factor: 2.816

3.  Impact of continuous positive airway pressure treatment on myocardial performance in patients with obstructive sleep apnea. A conventional and tissue Doppler echocardiographic study.

Authors:  George Karamanzanis; Fotios Panou; George Lazaros; Evangelos Oikonomou; Ioannis Nikolopoulos; Makrina Mihaelidou; George Ntounis; John Lekakis
Journal:  Sleep Breath       Date:  2014-07-03       Impact factor: 2.816

4.  Assessment of atrial electromechanical delay and influential factors in patients with obstructive sleep apnea.

Authors:  Julide Yagmur; Ozkan Yetkin; Mehmet Cansel; Nusret Acikgoz; Necip Ermis; Yasin Karakus; Hakan Tasolar
Journal:  Sleep Breath       Date:  2011-01-09       Impact factor: 2.816

Review 5.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

Review 6.  Obstructive Sleep Apnea in Heart Failure: Review of Prevalence, Treatment with Continuous Positive Airway Pressure, and Prognosis.

Authors:  Himad K Khattak; Faisal Hayat; Salpy V Pamboukian; Harvey S Hahn; Brian P Schwartz; Phyllis K Stein
Journal:  Tex Heart Inst J       Date:  2018-06-01

7.  The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice.

Authors:  Rachel E Nisbet; Anitra S Graves; Dean J Kleinhenz; Heidi L Rupnow; Alana L Reed; Tai-Hwang M Fan; Patrick O Mitchell; Roy L Sutliff; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-23       Impact factor: 6.914

8.  Treatment of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02

Review 9.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

10.  Continuous positive airway pressure therapy reduces right ventricular volume in patients with obstructive sleep apnea: a cardiovascular magnetic resonance study.

Authors:  Ulysses J Magalang; Kathryn Richards; Beth McCarthy; Ahmed Fathala; Meena Khan; Narasimham Parinandi; Subha V Raman
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.